All Chemistry World articles in Archive 2004-2009 – Page 116
-
Opinion
Blinkers for bad news
The Avandia controversy poses some tough questions about how to balance risks, says Derek Lowe
-
Business
Business roundup: July 2007
A depressing ruling for obesity drug A decision by a US Food and Drug Administration (FDA) advisory panel on 13 June was a double blow for French drug firm, Sanofi-Aventis. Their long-awaited obesity drug, rimonabant, marketed in Europe as Acomplia, was not recommended for approval by the FDA. ...
-
OpinionEditorial: Questioning the FDA
There will be mutterings of unrest in the corridors of the US Food and Drug Administration (FDA) this month
-
News
To chew or to burn?
Preview: Figuring out the best - and cheapest - ways of unlocking the energy stored in the cellulose, lignin and hemicellulose bound up in plant waste.
-
News
First internationally licensed Chinese herbal patent
China has licensed its first herbal compound patent to an overseas pharmaceutical company
-
News
Seeing the environmental wood for the nanotech trees
German environmentalists have issued a 24-page report on potential health and environmental risks of nanotechnology. But others question its value.
-
News
Why aspirin doesn't always stop blood clots
Some people are resistant to the blood-thinning properties of aspirin
-
News
Mimicking biophysics with water droplets
Drops of water have been micro-engineered into 'protocells'
-
News
Big pharma not interested in 'male pill'
German drug giant Bayer has officially stopped research and development of a hormonal male contraceptive
-
News
Boron is key to antifungal agent
Understanding the role of boron in a new antimicrobial compound could lead to new drugs
-
News
A mirror for the moon
Researchers have coated an ionic liquid with a reflective surface, making it (almost) suitable for a Moon-based telescope
-
News
More sugary solutions for petroleum substitutes
Independent research groups have arrived at different ways of converting sugars into fuels and feedstock
-
News
ICI to be sold?
ICI has rejected a £7.2 billion bid from Dutch chemical firm Akzo Nobel, rival bids are expected
-
News
Electrochemical screening for anti-cancer drugs
A test that predicts individual patient's response to chemotherapy
-
News
Sweet substitute for petroleum products
New method for converting sugars to chemical feedstock, replacing petroleum products
-
News
Renewed therapeutic promise for arthritis patients
News treatments for rheumatoid arthritis offer hope to patients where existing drugs have failed